Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the "Company”), a pharmaceutical company focused on developing new ...
Granite Creek invested in Odyssey in 2022 as part of a shareholder recapitalization led by the Company's majority owner, Equivu Capital. In 2023, Granite Creek provided additional capital to the ...